Albuterol Dosing for an 11-Year-Old Child
For an 11-year-old child with asthma, use weight-based dosing of 0.15 mg/kg (minimum 2.5 mg) via nebulizer every 20 minutes for 3 doses during acute exacerbations, then 0.15-0.3 mg/kg every 1-4 hours as needed; alternatively, use 4-8 puffs via MDI with spacer every 20 minutes for 3 doses, then every 1-4 hours as needed. 1
Acute Exacerbation Dosing
Nebulizer Administration
- Initial treatment: 0.15 mg/kg (minimum dose 2.5 mg) every 20 minutes for 3 doses
- Maintenance: 0.15-0.3 mg/kg (up to 10 mg) every 1-4 hours as needed
- Continuous nebulization: 0.5 mg/kg/hour for severe exacerbations 2
For an average 11-year-old weighing approximately 35-40 kg, this translates to:
- Initial doses: 5.25-6 mg per treatment (typically round to one full 2.5 mg vial plus one additional vial)
- Maintenance: 5.25-12 mg per treatment
MDI with Spacer (Equally Effective Alternative)
- Initial treatment: 4-8 puffs (360-720 mcg) every 20 minutes for 3 doses
- Maintenance: 4-8 puffs every 1-4 hours as needed 1, 2
The guidelines emphasize that MDI with valved holding chamber is as effective as nebulized therapy in mild-to-moderate exacerbations when proper technique is used 1. This is particularly important given recent supply chain issues with nebulizer solutions 3.
Routine/Maintenance Dosing
FDA-Approved Dosing
For children ≥2 years weighing ≥15 kg (which includes most 11-year-olds):
- Standard dose: 2.5 mg (one full vial of 0.083% solution) three to four times daily via nebulizer 4
- Duration: 5-15 minutes per treatment
Oral Formulations
While the question asks about albuterol dosing generally, oral formulations exist but are less commonly used:
- Extended-release tablets: 4 mg twice daily (can increase up to 12 mg twice daily) 5
- Regular syrup: 4 mg four times daily 6
However, inhaled formulations are strongly preferred as they provide faster onset, require lower doses, and have fewer systemic side effects.
Clinical Decision Algorithm
Severity assessment determines dosing frequency:
Mild-to-moderate exacerbation (FEV1 or PEF 40-69%):
- Inhaled SABA every 60 minutes
- Continue 1-3 hours if improving 1
Severe exacerbation (FEV1 or PEF <40%):
- Nebulized SABA plus ipratropium hourly or continuous
- Add systemic corticosteroids 1
Life-threatening exacerbation:
- Continuous nebulization at 0.5 mg/kg/hour
- Consider adjunct therapies (IV magnesium, heliox) 2
Important Safety Considerations
Monitoring Requirements
- Heart rate: Expected increase of 10-20 bpm is normal; doses above 3 mg in children may cause heart rate increases >10% 4
- Serum potassium: Repeated dosing can cause 20-25% asymptomatic decline in normokalemic children 1
- Tremor and hyperactivity: Common but typically not severe enough to discontinue therapy 7
Common Pitfall
Do not exceed recommended dosing frequency without medical reassessment. If a previously effective regimen fails to provide relief, this signals worsening asthma requiring therapy escalation, not simply more albuterol 4.
Delivery Method Considerations
- Nebulizer: May have higher incidence of adverse reactions compared to MDI in young children 8
- MDI with spacer: Requires proper technique but equally effective and more resource-efficient 9, 10
- Vibrating mesh nebulizer: Emerging alternative that conserves medication 3
Weight-Based Dosing Caveat
The 0.15 mg/kg dosing applies to children across a wide age range. For an 11-year-old at the upper end of the pediatric weight spectrum (approaching 50 kg), the calculated dose may approach or equal adult dosing (2.5-5 mg). The practical maximum per treatment is typically 10 mg for maintenance dosing 2.